CoChat

Proteomic signatures for identification of impaired glucose tolerance

Open access
Carrasco-Zanini, Julia, Pietzner, Maik, Lindbohm, Joni V., Wheeler, Eleanor, Oerton, Erin, Kerrison, Nicola, Simpson, Missy, Westacott, Matthew, Drolet, Dan, Kivimaki, Mika, Ostroff, Rachel, Williams, Stephen A., Wareham, Nicholas J., Langenberg, Claudia · 2022 · Nature Medicine
Cited by 52

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

The implementation of recommendations for type 2 diabetes (T2D) screening and diagnosis focuses on the measurement of glycated hemoglobin (HbA1c) and fasting glucose. This approach leaves a large number of individuals with isolated impaired glucose tolerance (iIGT), who are only detectable through oral glucose tolerance tests (OGTTs), at risk of diabetes and its severe complications. We applied machine learning to the proteomic profiles of a single fasted sample from 11,546 participants of the Fenland study to test discrimination of iIGT defined using the gold-standard OGTTs. We observed significantly improved discriminative performance by adding only three proteins (RTN4R, CBPM and GHR) to the best clinical model (AUROC = 0.80 (95% confidence interval: 0.79–0.86), P = 0.004), which we validated in an external cohort. Increased plasma levels of these candidate proteins were associated with an increased risk for future T2D in an independent cohort and were also increased in individuals genetically susceptible to impaired glucose homeostasis and T2D. Assessment of a limited number of proteins can identify individuals likely to be missed by current diagnostic strategies and at high risk of T2D and its complications. A new study combines large-scale proteomics and machine learning to identify proteins that can be used to identify individuals with isolated impaired glucose tolerance, who would otherwise only be detectable with oral glucose tolerance tests.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41591-022-02055-z

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 52

Metadata

Authors
Carrasco-Zanini, J., Pietzner, M., Lindbohm, J. V., Wheeler, E., Oerton, E., Kerrison, N., Simpson, M., Westacott, M., Drolet, D., Kivimaki, M., Ostroff, R., Williams, S. A., Wareham, N. J., & Langenberg, C.
Venue
Nature Medicine
Published
2022-11
Volume
28
Issue
11
Pages
2293-2300
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W4308766739
Cited by
52
References
21
FWCI
5.87
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Proteomic signatures for identification of impaired glucose tolerance. https://app.cochat.ai/papers/10.1038/s41591-022-02055-z
The paper
Carrasco-Zanini, J., Pietzner, M., Lindbohm, J. V., Wheeler, E., Oerton, E., Kerrison, N., Simpson, M., Westacott, M., Drolet, D., Kivimaki, M., Ostroff, R., Williams, S. A., Wareham, N. J., & Langenberg, C. (2022). Proteomic signatures for identification of impaired glucose tolerance. Nature Medicine. https://doi.org/10.1038/s41591-022-02055-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.